Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Apr 29;52(2):201-6.
doi: 10.1007/BF00439111.

Alteration of ethanol-induced changes in locomotor activity by adrenergic blockers in mice

Alteration of ethanol-induced changes in locomotor activity by adrenergic blockers in mice

J A Matchett et al. Psychopharmacology (Berl). .

Abstract

The effects of various doses of ethanol (ETOH) on spontaneous locomotor activity (SLMA) in mice were measured using photocell activity chambers. Of the 4 i.p. doses injected, the 2 lowest doses (0.5 and 1.0 g/kg) stimulated SLMA, the next higher dose (2.0 g/kg) produced a biphasic effect of depression followed by stimulation, and the highest dose (4.0 g/kg) depressed SLMA. The mechanism of the biphasic effect of the 2.0 g/kg dose was studied in tests with central catecholamine antagonists at various doses 30 min before ETOH. Doses of 5, 10, and 20 mg/kg of propranolol, a beta-receptor blocker, significantly antagonized the depressant effect of ETOH but had no influence on the stimulant effect. High doses (10 and 20 mg/kg) of phentolamine, an alpha-receptor blocker, significantly antagonized the stimulant phase of ETOH action but had no significant effect on the depressant phase. All doses (0.062-0.250 mg/kg) of spiroperidol, a dopaminergic blocking drug, significantly enhanced the SLMA depression produced by ETOH. These results indicate that the SLMA-depressant effect of ETOH may be mediated by central "beta-type" receptors, that the SLMA-stimulant effect of ETOH may be mediated by central "alpha-type" receptors, and that at least part of ETOH's action may be due to dopaminergic mechanisms.

PubMed Disclaimer

References

    1. J Pharm Pharmacol. 1971 Sep;23(9):718-9 - PubMed
    1. Psychopharmacologia. 1960 Jun 23;1:346-50 - PubMed
    1. Psychopharmacologia. 1972;26(3):307-12 - PubMed
    1. Acta Physiol Scand. 1962 Mar-Apr;54:193-9 - PubMed
    1. Science. 1975 Aug 29;189(4204):731-3 - PubMed

Publication types

LinkOut - more resources